| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000005.txt","as_of":"2026-04-03T11:12:58.166696+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000005.txt","company":"Whitehawk Therapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000005.txt","article_chars":2175,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_b2b4c153983d083d","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000005.txt","content_type":"text/plain","enriched_at":"2026-04-03T12:40:14.966911+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000005.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000005.txt","source_event_id":"evt_3a4ea2a74db8","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"b0deefb4f5b7cf41","kind":"sec_filing","published_at":"20260402","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.9,"dates_mentioned":["2026-04-02"],"entities":[{"asset_class":"equity","name":"Whitehawk Therapeutics, Inc.","relevance":"issuer","symbol":"WHWK","type":"company"}],"event_type":"listing","information_gaps":["No details on the total number of shares held by the reporting owner prior to this filing.","No financial implications or guidance provided in the filing."],"key_facts":["Filing date: April 2, 2026","Form type: 144","Reporting owner: David James Lennon","Shares to be sold: 5,100 to cover withholding taxes"],"numeric_claims":[{"label":"Shares to be sold","value":"5,100"}],"primary_claim":"Whitehawk Therapeutics, Inc. filed Form 144 on April 2, 2026.","relevance_score":0.5,"sentiment":"neutral","source_quality":"medium","summary":"Whitehawk Therapeutics, Inc. filed Form 144 on April 2, 2026, indicating a planned sale of shares by an officer to cover tax obligations related to restricted stock units.","topics":["SEC filing","Form 144","Whitehawk Therapeutics"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Whitehawk Therapeutics, Inc. \u00b7 Filed 20260402","ticker":"WHWK","tickers":["WHWK"],"title":"WHWK filed 144","url":"https://www.sec.gov/Archives/edgar/data/1422142/0001995275-26-000005.txt"}... |